{
  "ticker": "NTRA",
  "company_name": "Natera, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07214532",
      "title": "Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer",
      "status": "NOT_YET_RECRUITING",
      "phase": "NA",
      "condition": "Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)",
      "start_date": "2026-03",
      "completion_date": "2037-12-30",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT07340567",
      "title": "Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE3",
      "condition": "Colorectal Cancer",
      "start_date": "2026-05-01",
      "completion_date": "2035-11-01",
      "enrollment": 0,
      "sponsor": "UNICANCER"
    },
    {
      "nct_id": "NCT05175235",
      "title": "Nivolumab and Pembrolizumab Dose Optimisation in Solid Tumours With CURATE.AI Platform and Sequential ctDNA Measurements",
      "status": "UNKNOWN",
      "phase": "PHASE1, PHASE2",
      "condition": "Solid Tumor",
      "start_date": "2021-08-19",
      "completion_date": "2023-08-01",
      "enrollment": 0,
      "sponsor": "National University Hospital, Singapore"
    },
    {
      "nct_id": "NCT05756088",
      "title": "Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA",
      "status": "WITHDRAWN",
      "phase": "",
      "condition": "Cardiac Allograft Vasculopathy, Endothelial Dysfunction, Microvascular Coronary Artery Disease",
      "start_date": "2025-12",
      "completion_date": "2030-06",
      "enrollment": 0,
      "sponsor": "Yale University"
    },
    {
      "nct_id": "NCT05178576",
      "title": "A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy",
      "status": "WITHDRAWN",
      "phase": "PHASE2",
      "condition": "Colon Cancer",
      "start_date": "2022-06-24",
      "completion_date": "2027-02",
      "enrollment": 0,
      "sponsor": "NSABP Foundation Inc"
    },
    {
      "nct_id": "NCT04239703",
      "title": "Trifecta-Kidney cfDNA-MMDx Study",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Kidney Transplant Rejection",
      "start_date": "2019-12-01",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "University of Alberta"
    },
    {
      "nct_id": "NCT04264702",
      "title": "BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer",
      "status": "UNKNOWN",
      "phase": "",
      "condition": "Colorectal Cancer, Colon Cancer",
      "start_date": "2020-04-24",
      "completion_date": "2025-09",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT05914792",
      "title": "Longitudinal ctDNA Surveillance for Older Women With ER+ Breast Cancer Who Omit Surgery",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Breast Cancer",
      "start_date": "2022-04-19",
      "completion_date": "2026-07-01",
      "enrollment": 0,
      "sponsor": "University of Pittsburgh"
    },
    {
      "nct_id": "NCT06414603",
      "title": "A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy",
      "status": "RECRUITING",
      "phase": "NA",
      "condition": "Heart Transplant Failure and Rejection",
      "start_date": "2024-06-10",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Natera, Inc."
    },
    {
      "nct_id": "NCT05108428",
      "title": "Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "EARLY_PHASE1",
      "condition": "Rectal Adenocarcinoma",
      "start_date": "2021-12-23",
      "completion_date": "2026-10",
      "enrollment": 0,
      "sponsor": "H. Lee Moffitt Cancer Center and Research Institute"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "NA": 8,
      "PHASE3": 3,
      "PHASE1, PHASE2": 1,
      "": 28,
      "PHASE2": 5,
      "EARLY_PHASE1": 1,
      "PHASE1": 3,
      "PHASE2, PHASE3": 1
    },
    "by_status": {
      "NOT_YET_RECRUITING": 4,
      "UNKNOWN": 3,
      "WITHDRAWN": 5,
      "RECRUITING": 15,
      "ACTIVE_NOT_RECRUITING": 6,
      "COMPLETED": 13,
      "TERMINATED": 4
    },
    "active_trials": 21,
    "completed_trials": 13,
    "conditions": [
      "22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X, Sex Chromosome Abnormalities, Cri-du-Chat Syndrome, Angelman Syndrome, Prader-Willi Syndrome, 1p36 Deletion Syndrome",
      "Adnexal Mass",
      "Any Single Gene Disorder (Cystic Fibrosis, Tay-Sachs)",
      "Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer, Intrahepatic Cholangiocarcinoma, Perihilar Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma, Distal Bile Duct Cancer",
      "Breast Cancer",
      "Breast Cancer, Oestrogen Receptor Positive Breast Cancer",
      "Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement)",
      "Cancer of the Rectum",
      "Cardiac Allograft Vasculopathy, Endothelial Dysfunction, Microvascular Coronary Artery Disease",
      "Colon Adenocarcinoma, Colorectal Cancer",
      "Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma, Hepatocellular Carcinoma, Adenocarcinoma of Biliary Tract, Gallbladder Adenocarcinoma",
      "Colon Cancer",
      "Colorectal Cancer",
      "Colorectal Cancer Screening",
      "Colorectal Cancer, Colon Cancer",
      "Colorectal Cancer, Melanoma, Non-small Cell Lung Cancer",
      "Early and Locally Advanced Breast Cancer",
      "Gastrooesophageal Cancer",
      "Heart Transplant",
      "Heart Transplant Failure and Rejection",
      "Heart Transplant Rejection",
      "Hereditary Cancer Syndrome",
      "Kidney Diseases",
      "Kidney Transplant Rejection",
      "Locally Advanced Rectal Carcinoma, Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8",
      "Lung Transplant Rejection",
      "Lung Transplantation",
      "Melanoma",
      "Metastatic Colorectal Cancer",
      "Microdeletion Syndromes, Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities",
      "Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma",
      "Muscle-invasive Bladder Cancer",
      "Pancreatic Cancer",
      "Pregnancy Following IVF With PGS/PGD",
      "Rectal Adenocarcinoma",
      "Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8, Stage IIA Rectal Cancer AJCC v8, Stage IIB Rectal Cancer AJCC v8, Stage IIC Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8, Stage IIIA Rectal Cancer AJCC v8, Stage IIIB Rectal Cancer AJCC v8, Stage IIIC Rectal Cancer AJCC v8",
      "Single Gene Disorders",
      "Solid Tumor",
      "Spinal Muscular Atrophy (SMA), Carrier Screening, Genetic Testing",
      "Stage III Colon Cancer",
      "Transplant Rejection, Allograft Rejection, Complications",
      "Transplant;Failure,Kidney",
      "Trisomy 13, Trisomy 18, Trisomy 21, Aneuploidy",
      "Trisomy 13, Trisomy 18, Trisomy 21, Sex Chromosome Abnormalities",
      "Trisomy 21, Trisomy 18, Trisomy 13, Monosomy X",
      "Trisomy 21, Trisomy 18, Trisomy 13, Sex Chromosome Abnormalities, Microdeletion Syndromes",
      "Twin to Twin Transfusion Syndrome, Pregnancy Complications, Multiple Gestation; Maternal Care",
      "Urothelial Carcinoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:22.374592",
    "search_query": "Natera, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Natera,+Inc."
  }
}